Breast density decrease linked with lower cancer risk Targeted therapy battles late-stage lung cancerResearchers tailor treatment to tumour’s molecular signature Tamoxifen vs. raloxifene: Which is best for breast cancer prevention? Followup study further delineates the differences in effectiveness and toxicity between the two selective estrogen receptor modulators RF ablation heats up recurrent liver tumours Procedure offers less invasive option than repeat surgery for patients with hepatic colorectal metastases Treatment puts the freeze on inoperable cancer Cryotherapy demonstrates success in bone and soft tissue tumours Heat-activated chemotherapy for liver tumours on the horizon New prostate strategy reduces biopsy burden Canadian doctors are championing 5-alpha-reductase inhibitors as agents to suppress slow-growing tumours Pancreatic cancer treatment is pure gold Program uncovers hidden distress in cancer patients Waiting-room questionnaire could trigger referral to peer support groups or psychiatrists Tool predicts response to combo therapy in metastatic renal carcinoma Aim is to avoid cost and side-effects of dual treatment if chances of benefiting are low First Previous 68 69 70 71 72 Next Last
